Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Etoposide
×
Clear all
Filters
3
NCT04924101
2025-07-23
KEYNOTE-B99
Merck Sharp & Dohme LLC
Phase 2
Completed
126 enrolled